Capitol Hill Ephedra Hearings Start Wednesday July 23rd

The House Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce is holding hearings on the ephedra supplement industry running Wednesday and Thursday. Among those scheduled to testify are officials from Metabolife, Cytodyne Technologies and other companies.

These hearings, along with Bill S.722 proposed by Senator Durbin, could have a significant impact on the future of the US dietary supplement industry.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.